Paper · 6983069
Proliferation and differentiation of single hapten-specific B lymphocytes is promoted by T-cell factor(s) distinct from T-cell growth factor.
Pike BL and 4 others. Proc Natl Acad Sci U S A, 1982. Cited by 95 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Proliferation and differentiation of single hapten-specific B lymphocytes is promoted by T-cell factor(s) distinct from T-cell growth factor. Papers, record 6983069. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6983069
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Proliferation and differentiation of single hapten-specific B lymphocytes is promoted by T-cell factor(s) distinct from T-cell growth factor.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| B-Lymphocytes | Major topic |
| Growth Substances | Major topic |
| T-Lymphocytes | Major topic |
| Animals | |
| Cell Division | |
| Cells, Cultured | |
| Clone Cells | |
| Haptens | |
| Interleukin-4 | |
| Lymphocyte Activation | |
| Mice |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References25
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 5,033,418 | Potentiation of the T-lymphocyte response to mitogens. II. The cellular source of potentiating mediator(s). | J Exp Med | 1972 | https://conductscience.org/library/papers/5033418 | PubMed |
| 2 | 4,128,440 | Mechanism of activation of the bone marrow-derived lymphocyte. 3. A distinction between a macrophage-produced triggering signal and the amplifying effect on triggered B lymphocytes of allogeneic interactions. | J Exp Med | 1973 | https://conductscience.org/library/papers/4128440 | PubMed |
| 3 | 4,606,516 | Enhancement of the humoral response of T cell-depleted murine spleens by a factor derived from human monocytes in vitro. | J Immunol | 1974 | https://conductscience.org/library/papers/4606516 | PubMed |
| 4 | 1,094,630 | A third signal in B cell activation given by TRF. | Transplant Rev | 1975 | https://conductscience.org/library/papers/1094630 | PubMed |
| 5 | 57,094 | Single cell studies on the antibody-forming potential of fractionated, hapten-specific B lymphocytes. | Immunology | 1976 | https://conductscience.org/library/papers/57094 | PubMed |
| 6 | 1,083,394 | The nature of the cells generating B-lymphocyte colonies in vitro. | J Cell Physiol | 1976 | https://conductscience.org/library/papers/1083394 | PubMed |
| 7 | 303,681 | Regulation of B-lymphocyte clonal proliferation by stimulatory and inhibitory macrophage-derived factors. | J Exp Med | 1977 | https://conductscience.org/library/papers/303681 | PubMed |
| 8 | 304,866 | Improved procedure for the fraction and in vitro stimulation of hapten-specific B lymphocytes. | J Immunol | 1978 | https://conductscience.org/library/papers/304866 | PubMed |
| 9 | 350,592 | Sequential use of hapten-gelatin fractionation and fluorescence-activated cell sorting in the enrichment of hapten-specific B llymphocytes. | Eur J Immunol | 1978 | https://conductscience.org/library/papers/350592 | PubMed |
| 10 | 112,040 | Mechanisms of clonal abortion tolerogenesis. II. Clonal behaviour of immature B cells following exposure to anti-mu chain antibody. | Immunology | 1979 | https://conductscience.org/library/papers/112040 | PubMed |
1 to 10 of 25
See all 25 referencesCited by22
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 95 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 34,322,133 | Exploiting Single-Cell Tools in Gene and Cell Therapy. | Front Immunol | 2021 | https://conductscience.org/library/papers/34322133 | PubMed |
| 6,604,127 | Evidence for two distinct classes of murine B cell growth factors with activities in different functional assays. | J Exp Med | 1983 | https://conductscience.org/library/papers/6604127 | PubMed |
| 6,434,689 | Activated B cells express receptors for, and proliferate in response to, pure interleukin 2. | J Exp Med | 1984 | https://conductscience.org/library/papers/6434689 | PubMed |
| 6,334,854 | Human interleukin 2 can promote the growth and differentiation of single hapten-specific B cells in the presence of specific antigen. | Proc Natl Acad Sci U S A | 1984 | https://conductscience.org/library/papers/6334854 | PubMed |
| 6,232,611 | Single-cell studies on hapten-specific B cells: response to T-cell-dependent antigens. | Proc Natl Acad Sci U S A | 1984 | https://conductscience.org/library/papers/6232611 | PubMed |
| 6,227,678 | Dendritic cells induce T lymphocytes to release B cell-stimulating factors by an interleukin 2-dependent mechanism. | J Exp Med | 1983 | https://conductscience.org/library/papers/6227678 | PubMed |
| 6,092,511 | Expression of interleukin 2 receptors on activated human B cells. | J Exp Med | 1984 | https://conductscience.org/library/papers/6092511 | PubMed |
| 6,089,211 | Synergistic effects of antigen and soluble T-cell factors in B-lymphocyte activation. | Proc Natl Acad Sci U S A | 1984 | https://conductscience.org/library/papers/6089211 | PubMed |
| 3,889,907 | A high-efficiency cloning system for single hapten-specific B lymphocytes that is suitable for assay of putative growth and differentiation factors. | Proc Natl Acad Sci U S A | 1985 | https://conductscience.org/library/papers/3889907 | PubMed |
| 3,877,937 | Interleukin 1 can act as a B-cell growth and differentiation factor. | Proc Natl Acad Sci U S A | 1985 | https://conductscience.org/library/papers/3877937 | PubMed |
1 to 10 of 22
See all 22 cited byGenes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6983069
GET https://conductscience.org/api/papers/v1/6983069/references?page=2